During the 3rd Asia Cell & Gene Therapy (CGT) Innovation Summit 2023, which took place in Shanghai from April 3-4, 2023, a concurrent ceremony - "CGT Awards - Asia Pacific CGT Excellence Awards 2023" was held. EurekaBio made a captivating impression at the event by showcasing their cutting-edge product lineup, including the EuLV® lentiviral vector production system based on stable cell producer lines, CellSep® series cell processing system, and sterile tube welder. The company's commitment to exceptional product quality, first-rate customer service, extensive market expertise, and promising growth prospects earned them the well-deserved recognition as the "CGT Award - Most Innovative Intelligent Manufacturing Equipment Supplier of 2023".

The "CGT Awards - Asia Pacific CGT Excellence Awards 2023" competition, open to participants worldwide, serves as a pivotal platform that offers strong support for the advancement of translational research in the domain of cell and gene therapy. It facilitates exponential growth in the industry's research and development capabilities. A distinguished panel of experts meticulously evaluated the contestants based on a comprehensive set of criteria, encompassing technical practicality and innovation, market performance, customer evaluations, growth potential, as well as research paper publications and patent portfolios.
EurekaBio stood out among a multitude of competitors and secured the esteemed accolade of "CGT Award - Most Innovative Intelligent Manufacturing Equipment Supplier of 2023". This significant achievement substantiates the widespread recognition of EurekaBio's products and technologies within the industry, highlighting their unparalleled prowess in intelligence, professionalism, stability, and commercial viability. 
The Chinese CGT industry is currently at a crucial turning point, undergoing evolution and upgrading. Driven by the impetus of digitization and intelligent technologies, EurekaBio has embraced the noble mission of "Empowering CGT and Confronting the Toughest Challenges in the Industry". Through the synergistic integration of diverse disciplines such as artificial intelligence, computer science, and life science, EurekaBio will make unwavering efforts in delivering cutting-edge, intelligent solutions that comprehensively address the intricacies of cell therapy product manufacturing. By providing industry clients with unrivaled CGT biotechnology services, EurekaBio catalyzes the progress of CGT drug research and production, propelling holistic progress and prosperity within the CGT landscape.